SciELO - Scientific Electronic Library Online

vol.21 issue2What patients with bipolar disorder and major depressive disorder perceive as adverse life events precipitating a current major depressive episodeSociotropic personality traits positively correlate with the severity of social anxiety author indexsubject indexarticles search
Home Pagealphabetic serial listing  

South African Journal of Psychiatry

On-line version ISSN 2078-6786
Print version ISSN 1608-9685


DU TOIT, E et al. SSRI use in pregnancy: Evaluating the risks and benefits. S. Afr. j. psyc. [online]. 2015, vol.21, n.2, pp.48-53. ISSN 2078-6786.

Selective serotonin reuptake inhibitor (SSRI) antidepressants are considered the primary pharmacological treatment for moderate to severe depression during pregnancy. Data regarding the safety of their use during pregnancy remain controversial and conflicting. Decisions regarding the prescription of antidepressant treatment are often fraught with concern around potential harmful medication effects on the pregnancy, fetus and infant. Information on potential risks remains extremely varied and inconsistent across sources. This lack of clarity regarding drug safety brings significant uncertainty not only for treating physicians, but also for women seeking information about depression during pregnancy. This review aims to summarise and evaluate the current evidence base and to aid clinicians in performing a risk/benefit analysis for SSRI use during pregnancy and lactation.

        · text in English     · English ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License